PMVP: Eckler Matthew Joseph discloses securities transactions
By AlphaYouPublished Form 4
Eckler Matthew Joseph
Reporting filer
Eckler Matthew Joseph reported Grant or award in PMV Pharmaceuticals, Inc.: 84000 units of Stock Option (right to buy) (derivative), dated 2026-10-01. The full Form 4 contains 1 transaction entry.
- Disclosed
- Oct 5, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) (derivative) | Eckler Matthew Joseph | 2026-10-01 | A | Grant or award | 84000 | 0 | 84,000 | 4 days | Filed terms
|
Stock Option (right to buy) (derivative)
- Owner
- Eckler Matthew Joseph
- Date
- 2026-10-01
- Code
- A
- Action
- Grant or award
- Quantity
- 84000
- Price
- 0
- Following holdings
- 84,000
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 1.75
- transaction Date: 2026-10-01
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 84000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-10-01
- underlying Security Title: Common Stock
- underlying Security Shares: 84000
- shares Owned Following Transaction: 84000
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Eckler Matthew Joseph: Director.
- F1: Shares subject to the option vest in 36 equal monthly installments beginning on November 1, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.